South & Central America Prenatal Testing Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The South & Central America Prenatal Testing Services Market size is expected to reach US$ 65.7 Million by 2031 from US$ 26.1 Million in 2024. The market is estimated to record a CAGR of 14.5% from 2025 to 2031.

Executive Summary and South & Central America Prenatal Testing Services Market Analysis:

The South & Central America prenatal testing services market is categorized into Brazil, Argentina, Peru, Chile, Colombia, and the Rest of South & Central America. NIPT is accessible in the region, yet its acceptance is lower and more fragmented. According to worldwide assessments, NIPT is accessible in more than 60 countries, but only in certain parts of Latin America. Nevertheless, the mode of accessing these services is through urban areas, and those who can afford them pay on a self-pay basis. As public prenatal screening programs in the region are based on traditional biochemical screening, NIPT remains a supplementary addition to the existing public health offerings rather than a core program. Ethical and policy discussions here are largely reflective of those worldwide, with anxiety over informed consent, especially as NIPT becomes more accessible.

South & Central America Prenatal Testing Services Market: Strategic Insights

South & Central America Prenatal Testing Services Market Segmentation Analysis:

• By Diagnostic Type, the South & Central America Prenatal Testing Services Market is segmented into Non Invasive and Invasive. The Non Invasive segment dominated the market in 2024.
• By Disease, the South & Central America Prenatal Testing Services Market is segmented into Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others. The Aneuploidy segment dominated the market in 2024.
• By End User, the South & Central America Prenatal Testing Services Market is segmented into Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users. The Hospitals segment dominated the market in 2024.

South & Central America Prenatal Testing Services Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Prenatal Testing Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South & Central America Prenatal Testing Services Market Outlook

A significant amount of evidence from extensive cohort studies supports the fact that NIPT is a strong testing method even for women who are considered "average risk". According to data from Ariosa Diagnostics clinical lab, the percentage of NIPT samples from women under 35 (who are generally at a lower risk) increased from 47% in 2014 to more than 60% by 2017. This change suggests that patients and providers are increasingly confident in the usefulness of NIPT, even in cases where they do not have the traditional "high-risk" indications. Prenatal-care providers, by taking NIPT to groups that are not high-risk, can offer a much safer, more accurate screening option to a considerable number of pregnant women, thus decreasing the need for invasive procedures, minimizing the level of anxiety, and improving the early detection of risk. As clinical guidelines evolve and the public becomes increasingly aware of NIPT's effectiveness in average-risk populations, this shift drives the demand for prenatal testing services.

South & Central America Prenatal Testing Services Market Country Insights

By country, the South & Central America Prenatal Testing Services Market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2024.

In Brazil, prenatal testing, including NIPT, is in principle accessible. However, in practice, it is available through private healthcare providers and in urban areas only. A study conducted in Brazil demonstrated that cell-free fetal DNA (cfDNA) methods can be successfully applied in the public health sector. However, their prevalence remains low due to infrastructural limitations and high costs. A few public genetic testing facilities and diagnostic laboratories within the public health system possess the capability for cytogenetic or molecular testing. At the same time, advanced prenatal screening services are still conducted by private laboratories. Prenatal care in the public sector is primarily focused on congenital diseases. The Ministry of Health of Brazil admits that cfDNA-based screening, starting from the 9th-10th week, can identify trisomies (13, 18, 21) with very high sensitivity. But as NIPT is still not routinely covered by SUS, women have to pay for it from their own pockets or through private insurance. Ethical issues are still debated. In a scenario where abortion due to fetal indication is not allowed, medical professionals argue that NIPT might lead to complex decision-making. Hence, there is an acute need for counseling and the provision of social support services.

The availability of prenatal laboratory tests is highly different between various population groups. A nationally representative health survey-based study discovered that in 2019, only 69.9% of women had access to a defined set of prenatal tests, and the disadvantaged populations (those from low-income backgrounds, with low education, and living in rural areas) had lower coverage. Brazilian researchers are involved in developing affordable technologies for the future. An example of this is a publicly funded project aiming at making a noninvasive prenatal paternity test from cell-free fetal DNA a low-cost test for private and public users.

South & Central America Prenatal Testing Services Market Company Profiles

Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Illumina Inc, Quest Diagnostics Inc, Exact Sciences Corp, Eurofins Scientific SE, Myriad Genetics Inc, Revvity Inc, Laboratory Corp of America Holdings, MedGenome Inc, and Fulgent Genetics, Inc.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Prenatal Testing Services Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise